SII first to develop novel coronavirus vaccine candidate, expects to progress to human trials in six… EP News Bureau Feb 19, 2020 SII-Codagenix developed novel coronavirus vaccine strain first to progress to pre-clinical testing phase. Estimated cost of the…
